• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毛果芸香碱诱导的口部震颤被腺苷 A2A 拮抗剂 MSX-3 和 SCH58261 抑制,但不是被腺苷 A1 拮抗剂 DPCPX 抑制。

Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.

机构信息

Department of Psychology, University of Connecticut, Storrs, CT 06269-1020, USA.

出版信息

Pharmacol Biochem Behav. 2010 Feb;94(4):561-9. doi: 10.1016/j.pbb.2009.11.011. Epub 2009 Dec 1.

DOI:10.1016/j.pbb.2009.11.011
PMID:19958787
Abstract

Tremulous jaw movements in rats, which can be induced by dopamine (DA) antagonists, DA depletion, and cholinomimetics, have served as a useful model for studies of tremor. Although adenosine A(2A) antagonists can reduce the tremulous jaw movements induced by DA antagonists and DA depletion, there are conflicting reports about the interaction between adenosine antagonists and cholinomimetic drugs. The present studies investigated the ability of adenosine antagonists to reverse the tremorogenic effect of the muscarinic agonist pilocarpine. While the adenosine A(2A) antagonist MSX-3 was incapable of reversing the tremulous jaw movements induced by the 4.0mg/kg dose of pilocarpine, both MSX-3 and the adenosine A(2A) antagonist SCH58261 reversed the tremulous jaw movements elicited by 0.5mg/kg pilocarpine. Systemic administration of the adenosine A(1) antagonist DPCPX failed to reverse the tremulous jaw movements induced by either an acute 0.5mg/kg dose of the cholinomimetic pilocarpine or the DA D2 antagonist pimozide, indicating that the tremorolytic effects of adenosine antagonists may be receptor subtype specific. Behaviorally active doses of MSX-3 and SCH 58261 showed substantial in vivo occupancy of A(2A) receptors, but DPCPX did not. The results of these studies support the use of adenosine A(2A) antagonists for the treatment of tremor.

摘要

大鼠的下颌震颤运动可被多巴胺(DA)拮抗剂、DA 耗竭和拟胆碱药诱导,该模型已被广泛用于震颤研究。虽然腺苷 A(2A)拮抗剂可减少由 DA 拮抗剂和 DA 耗竭引起的下颌震颤运动,但关于腺苷拮抗剂与拟胆碱药之间的相互作用存在相互矛盾的报告。本研究探讨了腺苷拮抗剂逆转拟胆碱药毛果芸香碱引起震颤的能力。虽然腺苷 A(2A)拮抗剂 MSX-3 不能逆转 4.0mg/kg 毛果芸香碱剂量引起的下颌震颤运动,但 MSX-3 和腺苷 A(2A)拮抗剂 SCH58261 均能逆转 0.5mg/kg 毛果芸香碱引起的下颌震颤运动。腺苷 A(1)拮抗剂 DPCPX 全身给药不能逆转急性 0.5mg/kg 毛果芸香碱或 DA D2 拮抗剂匹莫齐特引起的下颌震颤运动,表明腺苷拮抗剂的震颤缓解作用可能具有受体亚型特异性。MSX-3 和 SCH 58261 的行为活性剂量对 A(2A)受体具有明显的体内占有率,但 DPCPX 则没有。这些研究的结果支持使用腺苷 A(2A)拮抗剂治疗震颤。

相似文献

1
Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.毛果芸香碱诱导的口部震颤被腺苷 A2A 拮抗剂 MSX-3 和 SCH58261 抑制,但不是被腺苷 A1 拮抗剂 DPCPX 抑制。
Pharmacol Biochem Behav. 2010 Feb;94(4):561-9. doi: 10.1016/j.pbb.2009.11.011. Epub 2009 Dec 1.
2
Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.条件性神经敲除腺苷 A(2A)受体和药理学 A(2A)拮抗作用可减少匹鲁卡品诱导的震颤下颌运动:帕金森震颤小鼠模型研究。
Eur Neuropsychopharmacol. 2013 Aug;23(8):972-7. doi: 10.1016/j.euroneuro.2012.08.004. Epub 2012 Sep 1.
3
Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.丘脑底核深部脑刺激可逆转帕金森病药物模型中的口部震颤:与腺苷 A2A 拮抗作用的相互影响。
Eur J Neurosci. 2013 Jul;38(1):2183-91. doi: 10.1111/ejn.12212. Epub 2013 Apr 18.
4
Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.腺苷A2A拮抗剂KW 6002(异他司特)对匹莫齐特诱导的口腔震颤和纹状体c-Fos表达的影响:与毒蕈碱拮抗剂托吡卡胺的比较。
Neuroscience. 2009 Sep 29;163(1):97-108. doi: 10.1016/j.neuroscience.2009.05.040. Epub 2009 May 23.
5
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.多巴胺与腺苷受体相互作用作为帕金森病治疗的基础。
J Neurol Sci. 2006 Oct 25;248(1-2):48-52. doi: 10.1016/j.jns.2006.05.038. Epub 2006 Jun 15.
6
Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.在药物诱导的帕金森震颤动物模型中,沙芬酰胺的震颤缓解作用。
Pharmacol Biochem Behav. 2013 Apr;105:105-11. doi: 10.1016/j.pbb.2013.01.015. Epub 2013 Jan 27.
7
The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.毒蕈碱受体拮抗剂托吡卡胺可抑制帕金森震颤啮齿动物模型中的下颌震颤:M4受体的可能作用
Psychopharmacology (Berl). 2007 Oct;194(3):347-59. doi: 10.1007/s00213-007-0844-6. Epub 2007 Jun 27.
8
Differential effects of adenosine antagonists in two models of parkinsonian tremor.腺苷拮抗剂在两种帕金森震颤模型中的差异效应。
Pharmacol Biochem Behav. 2009 Nov;94(1):24-9. doi: 10.1016/j.pbb.2009.07.001. Epub 2009 Jul 12.
9
Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.苍白球细胞外 GABA 在氟哌啶醇诱导口部震颤时增加,但在毒蕈碱受体刺激时不增加。
Behav Brain Res. 2012 Sep 1;234(1):129-35. doi: 10.1016/j.bbr.2012.06.011. Epub 2012 Jun 20.
10
Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.腺苷A2A拮抗剂的震颤解作用:对帕金森病的意义。
Front Biosci. 2008 May 1;13:3594-605. doi: 10.2741/2952.

引用本文的文献

1
Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases.神经退行性疾病中的内在无序蛋白质及含有内在无序区域的蛋白质
Biophys Rev. 2022 Jun 8;14(3):679-707. doi: 10.1007/s12551-022-00968-0. eCollection 2022 Jun.
2
Involvement of adenosine A and A receptors on guanosine-mediated anti-tremor effects in reserpinized mice.在利血平化小鼠中,腺苷 A 和 A 受体参与鸟苷介导的抗震颤作用。
Purinergic Signal. 2020 Sep;16(3):379-387. doi: 10.1007/s11302-020-09716-z. Epub 2020 Jul 28.
3
Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
选择性腺苷A受体拮抗剂在阿尔茨海默病APPswe/PS1dE9小鼠模型中的有益作用。
Front Mol Neurosci. 2018 Jul 12;11:235. doi: 10.3389/fnmol.2018.00235. eCollection 2018.
4
Remote control of movement disorders using a photoactive adenosine A receptor antagonist.使用光活性腺苷 A 受体拮抗剂远程控制运动障碍。
J Control Release. 2018 Aug 10;283:135-142. doi: 10.1016/j.jconrel.2018.05.033. Epub 2018 May 31.
5
Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats.评价 5′-氯-5′-脱氧-(±)-ENBA(一种强效且选择性的腺苷 A1 受体激动剂)在大鼠哈尔明诱导模型中的震颤缓解作用。
CNS Neurosci Ther. 2017 May;23(5):438-446. doi: 10.1111/cns.12692. Epub 2017 Mar 29.
6
Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat.与毛果芸香碱诱导的大鼠口腔震颤相关的丘脑底核和皮质局部场电位
Front Behav Neurosci. 2016 Jun 17;10:123. doi: 10.3389/fnbeh.2016.00123. eCollection 2016.
7
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.A2A 腺苷受体缺失对 Tau 病小鼠模型具有保护作用。
Mol Psychiatry. 2016 Jan;21(1):97-107. doi: 10.1038/mp.2014.151. Epub 2014 Dec 2.
8
A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.用于筛选抗帕金森病活性的运动障碍行为啮齿动物模型的批判性评价:以腺苷A(2A)受体拮抗剂为例
Neurotox Res. 2014 May;25(4):392-401. doi: 10.1007/s12640-013-9446-8. Epub 2013 Dec 10.
9
Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.帕金森震颤的震颤下颌运动模型的药理学和生理学特征:对震颤病理生理学的潜在见解。
Front Syst Neurosci. 2011 Jul 4;5:49. doi: 10.3389/fnsys.2011.00049. eCollection 2011.
10
Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists.腺苷拮抗剂对操作性行为的兴奋剂作用:选择性 A2A 和 A1 拮抗剂的不同作用。
Psychopharmacology (Berl). 2011 Jul;216(2):173-86. doi: 10.1007/s00213-011-2198-3. Epub 2011 Feb 24.